Activist investor Elliott takes big stake in drugmaker Catalent – WSJ
(Reuters) -Activist investor Elliott Investment has built a significant stake in Catalent and is pushing for a shake-up on the contract drug manufacturer’s board, the Wall Street Journal reported on Wednesday. Elliott has been talking to potential director candidates about joining a slate of nominees to run in a proxy contest, WSJ said, citing people…